⌘K

Login Start Free

Home/Filings/4/0000874716-25-000127

4//SEC Filing

Hunt Nimrata 4

Accession 0000874716-25-000127

CIK 0000874716other

View on SEC.gov Company Profile

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 9:00 PM ET

Size

19.3 KB

Accession

0000874716-25-000127

Insider Transaction Report

Form 4

Period: 2025-08-06

IDEXX LABORATORIES INC /DEIDXX

Executive Vice President

Transactions

Exercise/Conversion
Common Stock
2025-08-06$206.94/sh+5,711$1,181,834→ 25,149.944 total
Sale
Common Stock
2025-08-06$630.91/sh−2,907$1,834,052→ 19,224.944 total
Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2025-08-06−5,711→ 0 total
Exercise: $206.94Exp: 2029-02-13→ Common Stock (5,711 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2025-08-06−1,218→ 0 total
Exercise: $141.60Exp: 2027-02-13→ Common Stock (1,218 underlying)
Exercise/Conversion
Common Stock
2025-08-06$141.60/sh+1,218$172,469→ 13,573.944 total
Sale
Common Stock
2025-08-06$629.87/sh−3,018$1,900,933→ 22,131.944 total
Exercise/Conversion
Common Stock
2025-08-06$178.26/sh+5,865$1,045,495→ 19,438.944 total
Sale
Common Stock
2025-08-06$630.69/sh−1,218$768,179→ 18,006.944 total
Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2025-08-06−5,865→ 0 total
Exercise: $178.26Exp: 2028-02-13→ Common Stock (5,865 underlying)

Holdings

Common Stock
(indirect: By Spouse)
160

Footnotes (5)

[F1]Includes a total of 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
[F2]Represents the weighted average price of the shares sold ranging from a low of $630.50 to a high of $630.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
[F3]Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2018.
[F4]Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2019.
[F5]Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2020.

Documents

1 file

4
wk-form4_1754701209.xmlPrimary
FORM 4

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1

filerCIK 0001800619

Filing Metadata

Form type: 4
Filed: Aug 7, 8:00 PM ET
Accepted: Aug 8, 9:00 PM ET
Size: 19.3 KB

View on SEC.gov